Assignee
ZANDER THERAPEUTICS INC
US·4 granted patents·2 pending applications·2 citations·filing 2016–2019
Top patents by PatentIndex Score
6 records- 0178US10472351B2Small molecule agonists and antagonists of NR2F6 activity in animalsZANDER THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2019·2 cites·3 claims
- 0262US10716810B2Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytesZANDER THERAPEUTICS INC·Filed 2018·Granted Jul 21, 2020·0 cites·1 claims
- 0356US10030227B2Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytesZANDER THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·0 cites·16 claims
- 0455US2020071307A1Small molecule agonists and antagonists of nr2f6 activity in animalsZANDER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0554US11377442B2Small molecule agonists and antagonists of NR2F6 activityZANDER THERAPEUTICS INC·Filed 2018·Granted Jul 5, 2022·0 cites·4 claims
- 0633US2019054118A1Small Molecule Agonists and Antagonists of NR2F6 Activity in AnimalsZANDER THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →